Market Movers

Henry Schein, Inc.’s Stock Price Soars to $79.79, Marking a Robust Increase of +4.85%

By January 30, 2025 No Comments

Henry Schein, Inc. (HSIC)

79.79 USD +3.69 (+4.85%) Volume: 6.09M

Henry Schein, Inc.’s stock price is currently performing strongly at 79.79 USD, marking a positive trading session with a surge of +4.85%. With a robust trading volume of 6.09M, the company’s stock has also seen a solid year-to-date increase of +17.01%, reflecting its robust market presence and investor confidence.


Latest developments on Henry Schein, Inc.

Henry Schein, Inc. has seen significant movements in its stock price today following the announcement of a major strategic investment by KKR & Co. Inc. KKR has invested $250 million in the healthcare giant, acquiring a 12% stake in the company. This investment has led to changes in the company’s board, with two representatives from KKR joining. The deal comes amidst uncertainty over tariffs, with KKR citing Henry Schein’s ‘tremendous growth potential’ as a key reason for the investment. Mizuho Securities has also adjusted Henry Schein’s price target to $78, maintaining a neutral rating. Retail investors are cheering the deal, which signals confidence in Henry Schein’s future prospects.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars